Wnt Effector TCF4 Is Dispensable for Wnt Signaling in Human Cancer Cells
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
Grantová podpora
15-25100S
Grantová Agentura České Republiky
LO1419
Ministerstvo Školství, Mládeže a Tělovýchovy
RVO 68378050
Akademie Věd České Republiky
L200521751
Akademie Věd České Republiky
274815
Grantová Agentura, Univerzita Karlova
LM2015040
Ministerstvo Školství, Mládeže a Tělovýchovy
PubMed
30200414
PubMed Central
PMC6162433
DOI
10.3390/genes9090439
PII: genes9090439
Knihovny.cz E-zdroje
- Klíčová slova
- TCF7L2, Wnt signaling, colorectal cancer, conditional gene inactivation, epithelium, gut, organoids, tumorigenesis,
- Publikační typ
- časopisecké články MeSH
T-cell factor 4 (TCF4), together with β-catenin coactivator, functions as the major transcriptional mediator of the canonical wingless/integrated (Wnt) signaling pathway in the intestinal epithelium. The pathway activity is essential for both intestinal homeostasis and tumorigenesis. To date, several mouse models and cellular systems have been used to analyze TCF4 function. However, some findings were conflicting, especially those that were related to the defects observed in the mouse gastrointestinal tract after Tcf4 gene deletion, or to a potential tumor suppressive role of the gene in intestinal cancer cells or tumors. Here, we present the results obtained using a newly generated conditional Tcf4 allele that allows inactivation of all potential Tcf4 isoforms in the mouse tissue or small intestinal and colon organoids. We also employed the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system to disrupt the TCF4 gene in human cells. We showed that in adult mice, epithelial expression of Tcf4 is indispensable for cell proliferation and tumor initiation. However, in human cells, the TCF4 role is redundant with the related T-cell factor 1 (TCF1) and lymphoid enhancer-binding factor 1 (LEF1) transcription factors.
Faculty of Science Charles University Prague Albertov 6 Praha 128 43 Czech Republic
Institute of Molecular Genetics of the CAS v v i Videnska 1083 Prague 142 20 Czech Republic
Zobrazit více v PubMed
Clevers H., Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–1205. doi: 10.1016/j.cell.2012.05.012. PubMed DOI
Valenta T., Hausmann G., Basler K. The many faces and functions of beta-catenin. EMBO J. 2012;31:2714–2736. doi: 10.1038/emboj.2012.150. PubMed DOI PMC
Polakis P. Wnt signaling in cancer. Cold Spring Harb. Perspect. Biol. 2012;4:a008052. doi: 10.1101/cshperspect.a008052. PubMed DOI PMC
Krausova M., Korinek V. Signal transduction pathways participating in homeostasis and malignant transformation of the intestinal tissue. Neoplasma. 2012;59:708–718. doi: 10.4149/neo_2012_090. PubMed DOI
Van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., et al. The beta-catenin/Tcf-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 2002;111:241–250. doi: 10.1016/S0092-8674(02)01014-0. PubMed DOI
Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007. doi: 10.1038/nature06196. PubMed DOI
Fafilek B., Krausova M., Vojtechova M., Pospichalova V., Tumova L., Sloncova E., Huranova M., Stancikova J., Hlavata A., Svec J., et al. Troy, a tumor necrosis factor receptor family member, interacts with Lgr5 to inhibit Wnt signaling in intestinal stem cells. Gastroenterology. 2013;144:381–391. doi: 10.1053/j.gastro.2012.10.048. PubMed DOI
Clevers H., Loh K.M., Nusse R. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. Science. 2014;346:1248012. doi: 10.1126/science.1248012. PubMed DOI
Clevers H.C., Bevins C.L. Paneth cells: Maestros of the small intestinal crypts. Annu. Rev. Physiol. 2013;75:289–311. doi: 10.1146/annurev-physiol-030212-183744. PubMed DOI
Siegel R., DeSantis C., Virgo K., Stein K., Mariotto A., Smith T., Cooper D., Gansler T., Lerro C., Fedewa S., et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J. Clin. 2012;62:220–241. doi: 10.3322/caac.21149. PubMed DOI
Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC(-/-) colon carcinoma. Science. 1997;275:1784–1787. doi: 10.1126/science.275.5307.1784. PubMed DOI
Shimizu Y., Ikeda S., Fujimori M., Kodama S., Nakahara M., Okajima M., Asahara T. Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosom. Cancer. 2002;33:73–81. doi: 10.1002/gcc.1226. PubMed DOI
Liu W.G., Dong X.Y., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., Halling K.C., Cunningham J.M., Qian C.P., Christensen E., et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/tcf signalling. Nat. Genet. 2000;26:146–147. doi: 10.1038/79859. PubMed DOI
Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997;275:1787–1790. doi: 10.1126/science.275.5307.1787. PubMed DOI
Krausova M., Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell. Signal. 2014;26:570–579. doi: 10.1016/j.cellsig.2013.11.032. PubMed DOI
Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi: 10.1038/nature11252. PubMed DOI PMC
Tang W., Dodge M., Gundapaneni D., Michnoff C., Roth M., Lum L. A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc. Natl. Acad. Sci. USA. 2008;105:9697–9702. doi: 10.1073/pnas.0804709105. PubMed DOI PMC
Hrckulak D., Kolar M., Strnad H., Korinek V. TCF/LEF transcription factors: An update from the internet resources. Cancers. 2016;8:70. doi: 10.3390/cancers8070070. PubMed DOI PMC
Korinek V., Barker N., Moerer P., van Donselaar E., Huls G., Peters P.J., Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 1998;19:379–383. doi: 10.1038/1270. PubMed DOI
Van Es J.H., Haegebarth A., Kujala P., Itzkovitz S., Koo B.K., Boj S.F., Korving J., van den Born M., van Oudenaarden A., Robine S., et al. A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. Mol. Cell. Biol. 2012;32:1918–1927. doi: 10.1128/MCB.06288-11. PubMed DOI PMC
Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990;247:322–324. doi: 10.1126/science.2296722. PubMed DOI
Angus-Hill M.L., Elbert K.M., Hidalgo J., Capecchi M.R. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc. Natl. Acad. Sci. USA. 2011;108:4914–4919. doi: 10.1073/pnas.1102300108. PubMed DOI PMC
Rodriguez C.I., Buchholz F., Galloway J., Sequerra R., Kasper J., Ayala R., Stewart A.F., Dymecki S.M. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 2000;25:139–140. doi: 10.1038/75973. PubMed DOI
El Marjou F., Janssen K.P., Chang B.H.J., Li M., Hindie V., Chan L., Louvard D., Chambon P., Metzger D., Robine S. Tissue-specific and inducible cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–193. doi: 10.1002/gene.20042. PubMed DOI
Tumova L., Pombinho A.R., Vojtechova M., Stancikova J., Gradl D., Krausova M., Sloncova E., Horazna M., Kriz V., Machonova O., et al. Monensin inhibits canonical wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice. Mol. Cancer Ther. 2014;13:812–822. doi: 10.1158/1535-7163.MCT-13-0625. PubMed DOI
Xu Q., Wang Y.S., Dabdoub A., Smallwood P.M., Williams J., Woods C., Kelley M.W., Jiang L., Tasman W., Zhang K., et al. Vascular development in the retina and inner ear: Control by Norrin and Frizzled-4, a high-affinity ligand-receptor pair. Cell. 2004;116:883–895. doi: 10.1016/S0092-8674(04)00216-8. PubMed DOI
Sanjana N.E., Shalem O., Zhang F. Improved vectors and genome-wide libraries for crispr screening. Nat. Methods. 2014;11:783–784. doi: 10.1038/nmeth.3047. PubMed DOI PMC
Kasparek P., Krausova M., Haneckova R., Kriz V., Zbodakova O., Korinek V., Sedlacek R. Efficient gene targeting of the Rosa26 locus in mouse zygotes using TALE nucleases. FEBS Lett. 2014;588:3982–3988. doi: 10.1016/j.febslet.2014.09.014. PubMed DOI
Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature. 2009;459:262–265. doi: 10.1038/nature07935. PubMed DOI
Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G., van den Born M., Barker N., Shroyer N.F., van de Wetering M., Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469:415–418. doi: 10.1038/nature09637. PubMed DOI PMC
Valenta T., Lukas J., Korinek V. Hmg box transcription factor TCF-4’s interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells. Nucleic Acids Res. 2003;31:2369–2380. doi: 10.1093/nar/gkg346. PubMed DOI PMC
Lukas J., Mazna P., Valenta T., Doubravska L., Pospichalova V., Vojtechova M., Fafilek B., Ivanek R., Plachy J., Novak J., et al. Dazap2 modulates transcription driven by the Wnt effector TCF-4. Nucleic Acids Res. 2009;37:3007–3020. doi: 10.1093/nar/gkp179. PubMed DOI PMC
Veeman M.T., Slusarski D.C., Kaykas A., Louie S.H., Moon R.T. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Curr. Biol. 2003;13:680–685. doi: 10.1016/S0960-9822(03)00240-9. PubMed DOI
Janeckova L., Fafilek B., Krausova M., Horazna M., Vojtechova M., Alberich-Jorda M., Sloncova E., Galuskova K., Sedlacek R., Anderova M., et al. Wnt signaling inhibition deprives small intestinal stem cells of clonogenic capacity. Genesis. 2016;54:101–114. doi: 10.1002/dvg.22922. PubMed DOI PMC
Gregorieff A., Pinto D., Begthel H., Destree O., Kielman M., Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology. 2005;129:626–638. doi: 10.1016/j.gastro.2005.06.007. PubMed DOI
Buczacki S.J.A., Zecchini H.I., Nicholson A.M., Russell R., Vermeulen L., Kemp R., Winton D.J. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature. 2013;495:65–69. doi: 10.1038/nature11965. PubMed DOI
King J.B., von Furstenberg R.J., Smith B.J., McNaughton K.K., Galanko J.A., Henning S.J. Cd24 can be used to isolate Lgr5(+) putative colonic epithelial stem cells in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012;303:G443–G452. doi: 10.1152/ajpgi.00087.2012. PubMed DOI PMC
Yui S., Nakamura T., Sato T., Nemoto Y., Mizutani T., Zheng X., Ichinose S., Nagaishi T., Okamoto R., Tsuchiya K., et al. Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell. Nat. Med. 2012;18:618–623. doi: 10.1038/nm.2695. PubMed DOI
Lallemand Y., Luria V., Haffner-Krausz R., Lonai P. Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the cre site-specific recombinase. Transgen. Res. 1998;7:105–112. doi: 10.1023/A:1008868325009. PubMed DOI
Kennell J.A., O’Leary E.E., Gummow B.A., Hammer G.D., MacDougald O.A. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Mol. Cell. Biol. 2003;23:5366–5375. doi: 10.1128/MCB.23.15.5366-5375.2003. PubMed DOI PMC
Vacik T., Stubbs J.L., Lemke G. A novel mechanism for the transcriptional regulation of Wnt signaling in development. Genes Dev. 2011;25:1783–1795. doi: 10.1101/gad.17227011. PubMed DOI PMC
Hoverter N.P., Ting J.-H., Sundaresh S., Baldi P., Waterman M.L. A WNTt/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs. Mol. Cell. Biol. 2012;32:3648–3662. doi: 10.1128/MCB.06769-11. PubMed DOI PMC
Schuijers J., Mokry M., Hatzis P., Cuppen E., Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 2014;33:146–156. doi: 10.1002/embj.201385358. PubMed DOI PMC
Feil R., Wagner J., Metzger D., Chambon P. Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains. Biochem. Biophys. Res. Commun. 1997;237:752–757. doi: 10.1006/bbrc.1997.7124. PubMed DOI
Soriano P. Generalized lacZ expression with the ROSA26 cre reporter strain. Nat. Genet. 1999;21:70–71. doi: 10.1038/5007. PubMed DOI
Kuraguchi M., Wang X.-P., Bronson R.T., Rothenberg R., Ohene-Baah N.Y., Lund J.J., Kucherlapati M., Maas R.L., Kucherlapati R. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet. 2006;2:e146. doi: 10.1371/journal.pgen.0020146. PubMed DOI PMC
Powell A.E., Wang Y., Li Y.N., Poulin E.J., Means A.L., Washington M.K., Higginbotham J.N., Juchheim A., Prasad N., Levy S.E., et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell. 2012;149:146–158. doi: 10.1016/j.cell.2012.02.042. PubMed DOI PMC
Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., et al. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 2002;22:1184–1193. doi: 10.1128/MCB.22.4.1184-1193.2002. PubMed DOI PMC
Hovanes K., Li T.W.H., Munguia J.E., Truong T., Milovanovic T., Marsh J.L., Holcombe R.F., Waterman M.L. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 2001;28:53–57. doi: 10.1038/ng0501-53. PubMed DOI
Roose J., Huls G., van Beest M., Moerer P., van der Horn K., Goldschmeding R., Logtenberg T., Clevers H. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999;285:1923–1926. doi: 10.1126/science.285.5435.1923. PubMed DOI
Yan D., Wiesmann M., Rohan M., Chan V., Jefferson A.B., Guo L.D., Sakamoto D., Caothien R.H., Fuller J.H., Reinhard C., et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc. Natl. Acad. Sci. USA. 2001;98:14973–14978. doi: 10.1073/pnas.261574498. PubMed DOI PMC
Weidinger G., Thorpe C.J., Wuennenberg-Stapleton K., Ngai J., Moon R.T. The Sp1-related transcription factors sp5 and sp5-like act downstream of Wnt/beta-catenin signaling in mesoderm and neuroectoderm patterning. Curr. Biol. 2005;15:489–500. doi: 10.1016/j.cub.2005.01.041. PubMed DOI